State Street
IMNM icon

State Street’s Immunome IMNM Stock Holding History

State Street’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$118M Buy
5,399,901
+1,531,901
+40% +$34.1M ﹤0.01% 1285
2025
Q4 		$83.1M Buy
3,868,000
+1,064,027
+38% +$18.7M ﹤0.01% 1461
2025
Q3 		$32.8M Buy
2,803,973
+283,057
+11% +$2.82M ﹤0.01% 1966
2025
Q2 		$23.4M Sell
2,520,916
-119,527
-5% -$980K ﹤0.01% 2103
2025
Q1 		$17.8M Buy
2,640,443
+513,608
+24% +$4.93M ﹤0.01% 2201
2024
Q4 		$22.6M Sell
2,126,835
-60,631
-3% -$733K ﹤0.01% 2162
2024
Q3 		$32M Sell
2,187,466
-176,768
-7% -$2.51M ﹤0.01% 1933
2024
Q2 		$28.6M Buy
2,364,234
+2,163,543
+1,078% +$33.8M ﹤0.01% 1973
2024
Q1 		$4.95M Buy
200,691
+170,100
+556% +$3.45M ﹤0.01% 2929
2023
Q4 		$327K Buy
30,591
+1,000
+3% +$8.31K ﹤0.01% 3753
2023
Q3 		$247K Hold
29,591
– – ﹤0.01% 3874
2023
Q2 		$234K Hold
29,591
– – ﹤0.01% 3948
2023
Q1 		$148K Hold
29,591
– – ﹤0.01% 4173
2022
Q4 		$65.1K Hold
29,591
– – ﹤0.01% 4489
2022
Q3 		$131K Hold
29,591
– – ﹤0.01% 4341
2022
Q2 		$95K Hold
29,591
– – ﹤0.01% 4556
2022
Q1 		$168K Buy
29,591
+2,591
+10% +$19.4K ﹤0.01% 4445
2021
Q4 		$350K Buy
27,000
+14,300
+113% +$255K ﹤0.01% 4133
2021
Q3 		$309K Buy
+12,700
New +$222K ﹤0.01% 4182
2021
Q2 		– Sell
-32,550
Closed -$1.1M – 4480
2021
Q1 		$1.1M Buy
+32,550
New +$809K ﹤0.01% 3603

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street's IMNM Position: Q1 2026 in Review

State Street increased its Immunome (IMNM) stake by 40% in Q1 2026, buying an estimated $34.1M and bringing the position to 5,399,901 shares worth $118M. The position accounts for ﹤0.01% of the portfolio, ranked #1285.

State Street first reported a position in IMNM in Q1 2021 and has held it in 20 quarters since. 200 funds tracked by Wall St. Rank hold IMNM as of Q1 2026.

  • State Street held 5,399,901 shares of Immunome worth $118M as of Q1 2026.
  • State Street bought 1,531,901 Immunome shares in Q1 2026, an estimated $34.1M.
  • Immunome made up ﹤0.01% of State Street's portfolio in Q1 2026, its #1285 holding.
  • State Street first reported a position in Immunome in Q1 2021 and has held it in 20 quarters since.
  • 200 funds tracked by Wall St. Rank held Immunome as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.